Chemotherapy is needed before as well as after surgery. It helps to increase the survival rates among the patients of stomach cancer. The researchers of Royal Marsden Hospital in London and Surrey have concluded the study.
The New England Journal of Medicine has published the report. According to the Wall street Journal, this offers the most extensive medical evidence to support the preoperative therapy for stomach-cancer patients. Earlier studies had said that chemotherapy is not helpful after surgery.
Chemotherapy, before and after surgery decreased the death rate in stomach cancer by twenty-five percent in comparison with patients who only had surgery.